Research and Clinical Trials

Mayo Clinic researchers found disparities in data quality among racial groups in The Cancer Genome Atlas, one of the largest and most widely used cancer research datasets.

Advances in breast cancer prevention have resulted in new and innovative opportunities to modify breast cancer risk.

Researchers have learned you don't need a family history of colorectal cancer to have a genetic mutation that predisposes you to the disease.

A study is validating the use of genomic sequencing to predict the likelihood that patients with gastric cancer will derive benefit from therapies.

Research on adagrasib has demonstrated promising clinical activity in patients with gastrointestinal cancers that harbor KRAS G12C mutations.

Findings from a recent Mayo Clinic study suggest that knowledge of skin cancer risk could influence risky behavior, such as tanning bed use.

Mayo Clinic researchers may have discovered a genomic signature to predict which people with mesothelioma could benefit from immunotherapy.  

A Mayo Clinic study bolsters evidence that colorectal cancer is often imprinted in family genes and passed on from one generation to the next.

Folakemi Odedina, Ph.D., a Mayo Clinic cancer researcher and global health equity expert, explains why closing the care gap in cancer care is good for everyone.

A microbe in the uterine microbiome could be a contributing driver of endometrial cancer, according to a Mayo Clinic study.